Purchase Order 75N92022P00179
- Not listed
- This is a $664,873.38 firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a SYMPHONY S6 CELL SORTER. The contract does not have a set-aside designation, indicating BD competed for this award on an unrestricted basis. BD, a large medical technology manufacturer, specializes in flow cytometry, cell imaging, and genomics instruments...
- This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for maintenance services on BD Biosciences equipment, including the FACSymphony A5 and associated lasers. The $216,000 contract has a period of performance from November 7, 2022 to November 6, 2026 and does not utilize a small business set-aside. BD, a global medical technology company,...
- This is a $217,295.28 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a maintenance agreement covering BD Biosciences Symphony S6 and S5 flow cytometry instruments. The award is a follow-on to a request for quotes (RFQ) under simplified acquisition procedures and is not set aside for small businesses. BD, a global medical technology company, is the prime...
- Becton, Dickinson and Company's BD Biosciences division was awarded a $201,042 firm fixed-price purchase order by the National Heart Lung and Blood Institute (NHLBI) on April 1, 2025, for the Service Agreement Symphony A3 and Lasers. The contract, which operates without a small business set-aside, has an ultimate completion date of March 31, 2030, and will be performed in Bethesda, Maryland. Based on BD Biosciences' established federal contract portfolio, this award likely encompasses...
- This is a $764,203.60 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson & Co (BD), a large medical technology manufacturer. The contract is for a Becton Dickinson FACSymphony S6 cell sorter, which is a specialized flow cytometry instrument used for advanced medical research and clinical laboratory applications. The contract has a completion date of September 29, 2025. There is no...
- This is a $803,312.50 firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Becton, Dickinson and Company (BD) to provide a flow cytometry cell sorter equivalent to the FACSymphony S6. The contract has no set-aside designation and has an ultimate completion date of August 14, 2024. BD, a global medical technology manufacturer, has extensive experience providing specialized biomedical research...
- This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, to Becton, Dickinson and Company BD Biosciences for $1.22 million. The contract calls for BD Biosciences to provide two BD FACSymphony S6 Cell Sorters that meet the technical requirements specified in the solicitation for use by the Surgery Branch and Vaccine Branch at NCI facilities. Specifically, one instrument must...
- Becton, Dickinson and Company, operating through its BDB Division as BD Biosciences, was awarded a $10,422 firm fixed-price maintenance contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases for servicing a FACSMelody 9-color plate 4-way cell sorter. The contract was issued as a call under a Blanket Purchase Agreement on June 15, 2024, with completion required by December 14, 2024. Work will be performed at the NIAMS facility in Bethesda, Maryland. This award...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a purchase order valued at $24,924.63 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 30, 2025, covers a period of performance from December 29, 2025, through July 16, 2026, with an ultimate completion date of July 17, 2026. The award encompasses service contracts for...
This purchase order contract awards $328,914 to Becton, Dickinson and Company (BD Biosciences division) for service and maintenance of a BD FACSymphony S6 cell sorter and associated lasers at the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The contract represents the exercise of Option Period 4 (Calendar Year 5) under an existing firm fixed-price service agreement, with a completion date of June 18, 2027. The award was made without set-aside designation on June 14, 2022, reflecting BD's established position as a qualified large contractor for specialized flow cytometry instrumentation support to federal agencies. The FACSymphony S6 is a sophisticated cell sorting and analysis instrument essential to biomedical research capabilities at NIH. BD Biosciences' service scope typically encompasses preventive maintenance, corrective repairs, laser system support, software updates, priority on-site technical support, and comprehensive training for government research personnel. BD maintains an extensive federal contract portfolio across multiple NIH institutes and the Department of Veterans Affairs, with documented indefinite delivery vehicles and blanket purchase agreements valued in the millions of dollars for flow cytometry systems, reagents, and maintenance services, positioning the company as a critical supplier of advanced laboratory instrumentation to the federal biomedical research enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $65.8k | 4/26/26 | |
| P00003 | Exercise an Option | $65.8k | 4/30/25 | |
| P00002 | Exercise an Option | $65.8k | 6/6/24 | |
| P00001 | Exercise an Option | $65.8k | 6/8/23 | |
| Not listed | Not listed | $65.8k | 6/14/22 |